Endovascular Aneurysm Repair Devices as a Use Case for Postmarketing Surveillance of Medical Devices

The US Food and Drug Administration (FDA) is building a national postmarketing surveillance system for medical devices, moving to a "total product life cycle" approach whereby more limited premarketing data are balanced with postmarketing surveillance to capture rare adverse events and long-term safety issues.